Congratulations to our 27th Annual Meeting Award Winners! We can't wait to hear from them in just a few weeks at #ASGCT2024 . Learn more about these CGT experts on our blog. bit.ly/49v3ZLS

We're hosting a workshop on #RareDisease Clinical Trials on Tuesday, May 7, at the ASGCT Annual Meeting! Free for patients, caregivers and nonprofits.

Register to attend in-person or virtually today: bit.ly/3IwCA13

Listen to the NEW episode of the Molecular Therapy podcast with Marco!

Dr. Davila joins #MTO editor @Dr. Tim Cripe, M.D. Ph.D to discuss a recent article published in the December issue of #MTO by Dr. Davila and colleagues bit.ly/3TRSJ6v #AcuteMyeloidLeukemia . #AML

Who's looking forward to hearing from our #ASGCT2024 keynote speakers in ONE MONTH?

Meet our keynotes: Kevin Campbell (University of Iowa), Charles Murry (@UWMedicine), Beverly Davidson (@ChildrensPhila), + Philip Gregory (@2seventybio). bit.ly/48dIqPG

.U.S. FDA approves #CART #celltherapies #Abecma + #Carvykti for earlier #myeloma use. bit.ly/49spw7Y

Engineering Proteus mirabilis improves antitumor efficacy via enhancing cytotoxic T cell responses
hubs.li/Q02qnWMC0

Issue highlight from Molecular Therapy Oncology
Molecular Therapy @asgctherapy

Q: What lessons learned will play a role in the way scientists approach future research for #celltherapy + #genetherapy ?

In this #PatientEducation Community Quick Takes module, FDA Biologics's Dr. Peter Marks emphasizes platform technology, regulatory convergence, pilot program.

Registration is NOW open for our Global #GeneTherapy Training course through May 1!

Co-hosted by ASGCT + Muhimbili University this free course equips participants with knowledge + skills to educate students on advances in gene therapy. bit.ly/3xqyWn6

RESOURCE ALERT 📣 Our updated Clinical Trials Finder allows you to filter by condition, modality, location, status, + more! Users can also save filters for easy access on the next visit. Get connected to ongoing #genetherapy + #celltherapy trials. bit.ly/3ugZ3vt

Attend MORE Fireside Chats at #ASGCT2024 ! This year, learn from three separate chats that focus on the regulatory side of CGT, including two with FDA Biologics Director Peter Marks, and others with speakers from NCATS, ARPA-H, + more. bit.ly/3v4arus

The April issue of Molecular Therapy is out now! On the cover: A team from UC San Francisco showed multi-organ antisense oligonucleotide ( #ASO ) distribution in a mouse embryo section after a single in utero amniotic fluid injection.

Read the issue: bit.ly/3J5kFPe

It's officially election season at ASGCT + we need your help to select four new members of our Board of Directors! All current full and transitional members can VOTE through May 1 to help guide the Society's path forward.

Learn more + view the ballot. bit.ly/4ajUuQR

Come to #ASGCT2024 for the #genetherapy and #celltherapy science, but stay for the networking! Here are some opportunities during the meeting for you to meet new colleagues and reconnect with old ones. bit.ly/3UB6cl2

Check out this article from BioSpace on some recently approved #genetherapy + #celltherapy treatments, and learn what's coming up this year. bit.ly/3vxXR7D

We are FIVE weeks away from #ASGCT2024 ! Why are YOU joining us this year?

Here's what ASGCT Member Allison Bradbury, PhD (Nationwide Children's Hospital) said about attending the meeting.

Make sure you're registered + we'll see you in Baltimore! bit.ly/3v4arus

'Canavan research is part of my life, and to see #genetherapy make a difference, it’s just so satisfying,” says ASGCT Past Presideng Guangping Gao, PhD (UMass Chan Medical School). bit.ly/3xiqJ4h #CanavanDisease

The Exhibit Hall at #ASGCT2024 will be our largest + fullest yet! Make sure you visit the Hall to:
-learn from daily abstract poster receptions
-watch sponsored symposia
-network with colleagues over coffee + snacks
-browse 300+ exhibitor booths bit.ly/4azgI0J